We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-1 of 1

New guidance on the OIG’s ability to exclude owners, officers and managing employees; related FDA statements on pharmaceutical executives

  • Reed Smith LLP
  • -
  • USA
  • -
  • November 1 2010

On October 20, 2010, the Office of Inspector General (OIG) of the Department of Health and Human Services issued significant new guidance for implementing its permissive exclusion authority under Section 1128(b)(15) of the Social Security Act